Vimarsana
Biggest News Aggregation in the World

Page 12 - Multiple System News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Multiple System. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Multiple System Today - Breaking & Trending Today

Inhibikase Therapeutics Reports Second Quarter 2022 Financial Results and Highlights Recent Period Activity - Vimarsana News

Inhibikase Therapeutics Reports Second Quarter 2022 Financial Results and Highlights Recent Period Activity

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Source: apnews.com
Inhibikase Therapeutics Reports Second Quarter 2022 Financial Results and Highlights Recent Period Activity - Vimarsana News

Inhibikase Therapeutics Reports Second Quarter 2022 Financial Results and Highlights Recent Period Activity

/PRNewswire/ -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) ("Inhibikase" or "Company"), a clinical-stage pharmaceutical company developing therapeutics with...

Inhibikase Therapeutics Reports Second Quarter 2022 Financial Results and Highlights Recent Period Activity - Vimarsana News

Inhibikase Therapeutics Reports Second Quarter 2022 Financial Results and Highlights Recent Period Activity

Company to host conference call and webcast on Monday, August 15, 2022, at 8:00am ETBOSTON and ATLANTA, Aug. 12, 2022 /PRNewswire/ -- Inhibikase T...

Harold Clifford Gibson Jr. - Vimarsana News

Harold Clifford Gibson Jr.

Harold passed away Friday, April 29, 2022, from complications of Multiple System Atrophy.

Source: dnews.com
Alterity Therapeutics Announces Presentation of bioMUSE Data at the American Academy of Neurology (AAN) Annual Meeting - Vimarsana News

Alterity Therapeutics Announces Presentation of bioMUSE Data at the American Academy of Neurology (AAN) Annual Meeting

/PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying...